Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

CRISPR Therapeutics - Chart Of The Day

|About: CRISPR Therapeutics (CRSP)


100% technical buy signals.

11 new highs and up 89.05% in the last month.

140.86 gain in the last year.

The Chart of the Day belongs to CRISPR Therapeutics (CRSP).  I found the Biomedical stock by using Barchart to sort today's Top Stocks to Own list first by the highest Weighted Alpha, then I used the Flipchart feature to review the charts for consistent price appreciation.  Since the Trend Spotter signaled a buy in 12/18 the stock gained 122.62%.

CRISPR Therapeutics AG is a gene-editing company. It focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR Therapeutics AG is headquartered in Basel, Switzerland.


Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the web site when you read this report.

Barchart technical indicators:

  • 213.20+ weighted Alpha
  • 100% technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 11 new highs and up 89.05% in the last month
  • Relative Strength Index 82.17%
  • Technical support level at 40.72
  • Recently traded at 44.39 with a 50 day moving average of 23.67

Fundamental factors:

  • Market Cap $1.81 billion
  • Revenue and Earnings projections are all over the map
  • Wall Street analysts issued 1 strong buy, 2 buy and 3 hold recommendations on the stock
  • The individual investors on Motley Fool that follow the stock voted 36 to 1 that the stock will beat the market